Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - USD | 100.0% |
| 2022 | -4.18 Million USD | 48.13% |
| 2021 | -8.06 Million USD | -89.11% |
| 2020 | -19.93 Thousand USD | -13719.27% |
| 2019 | 3125.00 USD | -2472.25% |
| 2018 | -1200.00 USD | -445.45% |
| 2017 | -220.00 USD | 0.0% |
| 2014 | - USD | -2463.68% |
| 2013 | -3549.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2022 Q2 | -1.87 Million USD | -55.96% |
| 2022 Q1 | -1.2 Million USD | -91.99% |
| 2022 FY | - USD | 48.13% |
| 2022 Q4 | -167.42 Thousand USD | 82.06% |
| 2022 Q3 | -933.03 Thousand USD | 50.35% |
| 2021 FY | - USD | -89.11% |
| 2021 Q3 | -7.14 Million USD | -7413.67% |
| 2021 Q4 | -627.57 Thousand USD | 91.21% |
| 2021 Q2 | -95.06 Thousand USD | 52.71% |
| 2021 Q1 | -201.01 Thousand USD | 94.63% |
| 2020 FY | - USD | -13719.27% |
| 2020 Q4 | -3.74 Million USD | -721.36% |
| 2020 Q2 | -51.09 Thousand USD | -171.83% |
| 2020 Q1 | -18.79 Thousand USD | 11.58% |
| 2020 Q3 | -455.37 Thousand USD | -791.19% |
| 2019 Q4 | -21.25 Thousand USD | -136.0% |
| 2019 FY | - USD | -2472.25% |
| 2019 Q2 | -300.00 USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | -9008.00 USD | -2902.67% |
| 2018 FY | - USD | -445.45% |
| 2017 FY | - USD | 0.0% |
| 2015 Q3 | -1770.00 USD | 96.22% |
| 2015 Q1 | -122.48 Thousand USD | -120.93% |
| 2015 Q2 | -46.86 Thousand USD | 61.74% |
| 2014 Q1 | -29.54 Thousand USD | 14.16% |
| 2014 Q4 | -55.43 Thousand USD | -1021.11% |
| 2014 Q3 | -4945.00 USD | -368.28% |
| 2014 Q2 | -1056.00 USD | 96.43% |
| 2014 FY | - USD | -2463.68% |
| 2013 Q4 | -34.41 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 100.0% |
| Arrayit Corporation | -3.07 Million USD | 100.0% |
| Atlantic International Corp. | -5.38 Million USD | 100.0% |
| Biocept, Inc. | -30.24 Million USD | 100.0% |
| Bioqual, Inc. | 3.03 Million USD | 100.0% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 100.0% |
| DermTech, Inc. | -97.89 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 100.0% |
| iMD Companies, Inc. | -154.65 Thousand USD | 100.0% |
| IDenta Corp. | 71.58 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 100.0% |
| InVitro International | 6680.00 USD | 100.0% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 100.0% |
| Medical Imaging Corp. | -896.74 Thousand USD | 100.0% |
| NovelStem International Corp. | -3.78 Million USD | 100.0% |
| Optigenex Inc. | -1.18 Million USD | 100.0% |
| PharmChem, Inc. | 1.05 Million USD | 100.0% |
| Proteome Sciences plc | -1.13 Million USD | 100.0% |
| Response Genetics, Inc | -19.66 Million USD | 100.0% |
| Rennova Health, Inc. | -234.81 Thousand USD | 100.0% |
| RushNet, Inc. | -614.85 Thousand USD | 100.0% |
| ScreenPro Security Inc. | -3.43 Million USD | 100.0% |
| Stella Diagnostics Inc. | -5.7 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 100.0% |
| Todos Medical Ltd. | -9.39 Million USD | 100.0% |